The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

The FDA decision applies to both tobacco- and menthol-flavored versions of the reusable product, which works with ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology indications and cancer types.

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer Lykke Hinsch Gylvin, M.D., set out the German drugmaker's plans to launch ...

The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.

The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...

Health officials say smoking has been at a high rate in Eastern Kentucky and e-cigarettes are still considered dangerous.

His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs.

Following a prolonged and high-stakes legal battle, the U.S. Food and Drug Administration (FDA) granted Juul marketing ...

WASHINGTON - It probably sits waiting, largely unnoticed, on the shelves of every smoke shop, convenience store and gas ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping its gene therapy.